Medicine for treating radiation enteritis, and preparation method and application thereof

A radiation enteritis and drug technology, applied in the field of medicine, achieves the effects of short production cycle, easy-to-obtain raw materials, and low price

Inactive Publication Date: 2017-03-08
ZHENGZHOU ZHANGMENG NETWORK TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no effective treatment drug or method. Most of the medical institutions use symptomatic treatment, and the drugs used are also diff

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] In an embodiment of the present invention, a medicine for treating radiation enteritis is composed of the following raw materials in parts by weight: 3 parts of rabeprazole, 11 parts of astragalus extract, 5 parts of taurine, and 1 part of calcium pyruvate.

[0019] Mix rabeprazole, astragalus extract, and calcium pyruvate, add 3.1 times the mass of deionized water, raise the temperature to 75°C, and stir at this temperature for 38 minutes to prepare mixture A. The mixture A was mixed with taurine, subjected to ultrasonic treatment at 58° C. for 25 minutes with an ultrasonic power of 900 W, and then stirred at 63° C. until dry to obtain the drug.

Embodiment 2

[0021] In an embodiment of the present invention, a medicine for treating radiation enteritis is composed of the following raw materials in parts by weight: 7 parts of rabeprazole, 19 parts of astragalus extract, 13 parts of taurine, and 5 parts of calcium pyruvate.

[0022] Mix rabeprazole, astragalus extract, and calcium pyruvate, add 3.1 times the mass of deionized water, raise the temperature to 77°C, and stir at this temperature for 40 minutes to prepare mixture A. The mixture A was mixed with taurine, subjected to ultrasonic treatment at 58° C. for 25 minutes with an ultrasonic power of 900 W, and then stirred at 63° C. until dry to obtain the drug.

Embodiment 3

[0024] In an embodiment of the present invention, a medicine for treating radiation enteritis is composed of the following raw materials in parts by weight: 4 parts of rabeprazole, 13 parts of astragalus extract, 7 parts of taurine, and 2 parts of calcium pyruvate.

[0025] Mix rabeprazole, astragalus extract, and calcium pyruvate, add 3.1 times the mass of deionized water, raise the temperature to 76°C, and stir at this temperature for 39 minutes to prepare mixture A. The mixture A was mixed with taurine, subjected to ultrasonic treatment at 58° C. for 25 minutes with an ultrasonic power of 900 W, and then stirred at 63° C. until dry to obtain the drug.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating radiation enteritis and a preparation method thereof. The medicine is composed of the following raw materials in parts by weight: 3-7 parts of rabeprazole, 11-19 parts of radix astragali extract, 5-13 parts of taurine and 1-5 parts of calcium pyruvate. The preparation method comprises the following steps: mixing the rabeprazole, radix astragali extract and calcium pyruvate, adding deionized water, heating to 75-77 DEG C, and stirring for 38-40 minutes to obtain a mixture A; mixing the mixture A with the taurine, carrying out ultrasonic treatment at 58 DEG C under the ultrasonic power of 900W for 25 minutes, and stirring at 63 DEG C to a dry state, thereby obtaining the medicine. The medicine for treating radiation enteritis has the characteristics of unique composition and low price, is safe and convenient, and has better effects than the conventional western medicine. The medicine for treating radiation enteritis can effectively cure the colon and recta injuries caused by radiotherapy, and has the advantages of high cure rate, quick effect taking, no toxic or side effect, and no relapse after curing. The preparation method has the advantages of simple preparation technique, simple and accessible raw materials, short production cycle and low cost, and is suitable for industrial production and large-scale popularization.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating radiation enteritis and its preparation method and application. Background technique [0002] Radiation enteritis is an intestinal complication caused by radiotherapy for malignant tumors in the pelvic cavity, abdominal cavity, and retroperitoneum. The small intestine, colon, and rectum can be involved respectively, so it is also called radiation rectum, colon, and enteritis. Radiation sickness is generally divided into two types: acute and chronic, according to the radiation dose, time, and severity of the intestinal tract. According to the different positions inside and outside the body where the radiation source is placed, it can be divided into external radiation sickness and internal radiation sickness. In the early stage, the renewal of intestinal mucosal cells is inhibited, and later the arteriole wall is swollen and occluded, causing intestinal ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/481A61P1/00A61K31/185A61K31/19A61K31/4439
CPCA61K31/4439A61K31/185A61K31/19A61K36/481
Inventor 不公告发明人
Owner ZHENGZHOU ZHANGMENG NETWORK TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products